SARS-CoV-2 reinfection and implications for vaccine development

Author:

Nainu Firzan1,Abidin Rufika Shari2,Bahar Muh. Akbar1,Frediansyah Andri34,Emran Talha Bin5,Rabaan Ali A6ORCID,Dhama Kuldeep7ORCID,Harapan Harapan8910ORCID

Affiliation:

1. Faculty of Pharmacy, Hasanuddin University, 90245, Tamalanrea, Makassar, Indonesia

2. Faculty of Medicine, Hasanuddin University, 90245, Tamalanrea, Makassar, Indonesia

3. Research Division for Natural Product Technology (BPTBA), Indonesian Institute of Sciences (LIPI), 55861, Wonosari, Indonesia

4. Department of Pharmaceutical Biology, Pharmaceutical Institute, University of Tübingen, 72076, Tübingen, Germany

5. Department of Pharmacy, BGC Trust University Bangladesh, 4381, Chittagong, Bangladesh

6. Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, 31311, Dhahran, Saudi Arabia

7. Division of Pathology, ICAR-Indian Veterinary Research Institute, 243122, Izatnagar, Bareilly, Uttar Pradesh, India

8. Medical Research Unit, School of Medicine, Universitas Syiah Kuala, 23111, Banda Aceh, Indonesia

9. Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, 23111, Banda Aceh, Indonesia

10. Department of Microbiology, School of Medicine, Universitas Syiah Kuala, 23111, Banda Aceh, Indonesia

Funder

external funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3